When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...

Summit Therapeutics (NASDAQ:SMMT), a drug developer challenging pharma giant Merck's (NYSE:MRK) dominance in lung cancer, won ...

Merck's Gardasil vaccine, previously only available to women, has now been approved for men in China. This approval may help ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...

GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males ...

US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved ...

U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...

U.S. drugmaker Merck & Co on Wednesday announced that its human papillomavirus (HPV) vaccine for men has been approved by ...

China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

WuXi Biologics agreed to sell an overseas vaccine facility to Merck & Co. for half a billion dollars, a move that could strengthen the company's cash flow and margins as it navigates global ...